Press release
U.S Polycystic Ovary Syndrome Treatment Market is Likely to be Worth a Cumulative US$ 313.2 Million by 2024
Prevalence of endocrine diseases in the US is on a rise as the country’s urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and polycystic ovarian syndrome (PCOS) continues to alarm public health authorities across the US. Measures undertaken by non-profit organizations and US health regulatory bodies are promoting the awareness of PCOS treatments. Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical needs of people suffering from such complications. Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research’s recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR of 3.9% to reach US$ 313.2 Mn by the end of 2024.The foremost growth inhibitor for polycystic ovary syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment. Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.
Titled as “Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024,” the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the US polycystic ovary syndrome treatment market. Through 2024, oral contraceptives will be exhibiting a steady revenue growth at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.
More than 47% of US polycystic ovary syndrome treatment market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value CAGR of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14317
Key companies partaking in the growth of the US polycystic ovary syndrome treatment market include Sanofi, Novartis AG, Merck KGaA, Teva Pharmaceutical Industries Limited, and AstraZeneca plc.
To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/14317
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S Polycystic Ovary Syndrome Treatment Market is Likely to be Worth a Cumulative US$ 313.2 Million by 2024 here
News-ID: 541038 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for PCOS
Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728
Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis…
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this…
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,…
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with…
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy
PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.…
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10043
PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms…